Table 4 Diagnostic efficacy of various indicators on ovarian cancer
Item | SE(%) | SP(%) | PPV(%) | NPV(%) | Accuracy(%) | Youden index(%) | |
|---|---|---|---|---|---|---|---|
Serum | CA125(U/mL) | 75 | 66.8 | 34.4 | 92.0 | 70.9 | 41.8 |
| Â | HE4(pmol/L) | 63.6 | 95.8 | 77.8 | 91.9 | 79.7 | 59.4 |
| Â | Premenopausal | 57.1 | 95.3 | 66.7 | 93.1 | 76.2 | 52.4 |
| Â | Postmenopausal | 73.3 | 100 | 100 | 83.3 | 86.65 | 73.3 |
Serum sEVs | OCS | 77.3 | 93.2 | 72.3 | 90.9 | 85.25 | 70.5 |
CA125(U/mL) | 61.4 | 96.3 | 75 | 91.4 | 78.85 | 57.7 | |
HE4(pmol/L) | 77.3 | 73.7 | 40,5 | 93.3 | 75.5 | 51 | |
C5a(ng/ml) | 68.2 | 77.9 | 41.7 | 91.4 | 73.05 | 46.1 | |
ROMA | 63.6 | 81.1 | 43.8 | 90.6 | 72.35 | 44.7 | |
Premenopausal | 60.7 | 80.6 | 34.0 | 92.6 | 70.65 | 41.3 | |
Postmenopausal | 66.7 | 85 | 76.9 | 77.3 | 75.85 | 51.7 | |